Yas Holding Collaborates with Alvogen to Commercialize its Generic Portfolio in MENA Region

Alvogen Collaborates with Yas Holding to Commercialize its Generic Portfolio in MENA Region

Shots:

  • Yas Holding entered into an exclusive license and distribution agreement with Alvogen to commercialize its targeted generic pharmaceuticals portfolio in MENA region
  • The collaboration will expand Alvogen’s presence in the MENA region including Gulf, KSA, Levant, North Africa and Sub-Saharan Africa and will improve clinical outcomes and QoL of patients in the MENA region
  • Alvogen’s generic portfolio comprises of 28 products for oncology, autoimmune, inflammation and blood diseases and will be commercialized from 2020

Click here to­ read full press release/ article | Ref: Alvogen | Image: Alvogen